hotspot -WSS

hotspot

author：Wikipedia 2025-09-03 05:29:40 - browse：3

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： What’s missing from the debate over nursing home staff minimums

explore

WSS

What’s missing from the debate over nursing home staff minimums

Medicare Advantage plans can’t deny care with AI, CMS warns

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Transgender sports debate: Physicians say bans are health issue

Why the quest to eradicate polio has stumbled

Free Covid tests will again be offered to all U.S. households

hotspot

hotspot

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

FDA weighs limits of animal data in assessing artificial wombs

United colonoscopy coverage change 'may cost lives,' doctors say

Unique patient identifier: Experts argue the benefits, pitfalls

Medicare details structure of new drug price negotiation program

Padmanee Sharma of MD Anderson at center of lawsuit over credit

DIEP, the 'gold standard' of breast reconstruction, is under threat

Problems with a popular proposal to regulate AI in health care

Drug repurposing or repositioning? The language matters

Chamber of Commerce, DOJ clash in court over drug prices

entertainment

People with substance use disorder deserve online privacy

The struggle to figure out which patients 'deserve' Wegovy

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Unique patient identifier: Experts argue the benefits, pitfalls

Readout Newsletter: Amgen, Regeneron, BGI Group and more

hotspot

explore

explore

entertainment